Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Alterations in G-proteins in congestive heart failure in cardiomyopathic (UM-X7.1) hamsters

  • 20 Accesses

  • 21 Citations

Abstract

In order to explain the attenuated sympathetic support during the development of heart failure, the status of β-adrenergic mechanisms in the failing myocardium was assessed by employing cardiomyopathic hamsters (155–170 days old) at moderate degree of congestive heart failure. The norepinephrine turnover rate was increased but the norepinephrine content was decreased in cardiomyopathic hearts. The number and the affinity of β receptors in the sarcolemmal preparations were not changed in these hearts at moderate stage of congestive heart failure. While the basal adenylyl cyclase activity was not altered in sarcolemma, the stimulation of enzyme activity by NaF, forskolin, Gpp(NH)p or epinephrine was depressed in hearts from these cardiomyopathic hamsters. Since G-proteins are involved in modifying the adenylyl cyclase activity, the functional and bioactivities as well as contents of both Gs and Gi proteins were determined in the cardiomyopathic heart sarcolemma. The functional stimulation of adenylyl cyclase by cholera toxin, which activates Gs proteins, was markedly depressed whereas that by Pertussis toxin, which inhibits Gi proteins, was markedly augmented in cardiomyopathic hearts. The cholera toxin and pertussis toxin catalyzed ADP-ribosylation was increased by 37 and 126%, respectively; this indicated increased bioactivities of both Gs and Gi proteins in experimental preparations. The immunoblot analysis suggested 74 and 124% increase in Gs and Gi contents in failing hearts, respectively. These results suggest that depressed adenylyl cyclase activation in cardiomyopathic hamsters may not only be due to increased content and bioactivity of Gi proteins but the functional uncoupling of Gs proteins from the adenylyl cyclase enzyme may also be involved at this stage of heart failure.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Dhalla NS, Ziegelhoffer A, Harrow JAC: Regulatory role of membrane systems in heart function. Can J Physiol Pharmacol 55: 1211–1234, 1977

  2. 2.

    Stiles GL, Caron MG, Lefkowitz RJ: Beta adrenergic receptors: biochemical mechanisms of physiological regulation. Physiol Rev 64: 661–743, 1984

  3. 3.

    Homcy CJ, Vatner SF, Vatner DE: Beta adrenergic receptor regulation in the heart in pathophysiologic states: abnormal adrenergic responsiveness in cardiac disease. Annu Rev Physiol 53: 137–59, 1991

  4. 4.

    Pan TH, Liang CS, Kawashima S, Banerjee SP: Alterations in cardiac beta-adrenoceptor responsiveness and adenylate cyclase system by congestive heart failure in dogs. Eur J Pharmacol 140: 123–132, 1987

  5. 5.

    Dixon IMC, Dhalla NS: Alterations in cardiac adrenoceptor in congestive heart failure secondary to myocardial infarction. Coronary Artery Disease 2: 805–814, 1991

  6. 6.

    Karliner JS, Barnes P, Brown M, Dollery C: Chronic heart failure in the guinea pig increases cardiac α-1 and β-adrenergic adrenoceptors. Eur J Pharmacol 67: 115–118, 1980

  7. 7.

    Chasteney EA, Liang CS, Hood WB Jr: Beta adrenoceptor and adenylate cyclase function in the infarct model of heart failure. Proc Soc Exp Biol Med 200: 90–94, 1992

  8. 8.

    Karliner JS, Stevens M, Grattan M, Woloszym W, Honbo N, Hoffman JIE: Beta adrenergic receptor properties of canine myocardium: effects of chronic myocardial infarction. J Am Coll Cardiol 8: 349–356, 1986

  9. 9.

    Calderone A, Bouvier M, Li K, Juneau C, de Champlain J, Rouleau JL: Dysfunction of the β and α adrenergic system in a model of congestive heart failure. The pacing overdrive dog. Circ Res 69: 332–343, 1991

  10. 10.

    Sulakhe PV, Dhalla NS: Adenyl cyclase activity in failing hearts of genetically myopathic hamsters. Biochem Med 6: 471–482, 1972

  11. 11.

    Dhalla NS, Sulakhe PV: Adenyl cyclase activities of the subcellular membranes of the genetically myopathic hamsters. Biochem Med 9: 368–372, 1974

  12. 12.

    Harrow JAC, Singh JN, Jasmin G, Dhalla NS: Studies on adenylate cyclase-cyclic AMP system of the myopathic hamsters (UM-X7.1) skeletal and cardiac muscles. Can J Biochem 53: 1122–1127, 1975

  13. 13.

    Singh JN, Dhalla NS, McNamara DB, Bajusz E, Jasmin G: Membrane alterations in failing hearts of cardiomyopathic hamsters. Rec Adv Card Struc Met 6: 259–268, 1975

  14. 14.

    Dhalla NS, Singh JN, Bajusz E, Jasmin G: Comparison of heart sarcolemmal enzyme activities in normal and cardiomyopathic (UM-X7.1) hamsters. Clin Sci Mol Med 51: 233–242, 1976

  15. 15.

    Kessler PD, Cates AE, Van Dop C, Feldman AM: Decreased bioactivity of the guanine nucleotide binding protein that stimulates adenylate cyclase in hearts from cardiomyopathic Syrian hamsters. J Clin Invest 84: 244–252, 1989

  16. 16.

    Ikegaya T, Kobayashi A, Hough RB, Masuda H, Kaneko M, Yamazaki N: Stimulatory guanine nucleotide-binding protein and adenylate cyclase activities in BIO 14.6 cardiomyopathic hamsters at the hypertrophic stage. Mol Cell Biochem 110: 83–90, 1992

  17. 17.

    Sethi R, Panagia V, Dhalla KS, Beamish RE, Jasmin G, Dhalla NS: Status of β-adrenergic mechanisms during the development of congestive heart failure in cardiomyopathic hamsters (UM-X7.1). In: M. Nagano, N. Takeda and N.S. Dhalla (eds.). The Cardiomyopathic Heart. Raven Press, New York, 1994, pp 73–86

  18. 18.

    Jasmin G, Proschek L: Heriditary polymyopathy and cardiomyopathy in the Syrian Hamster. I. Progression of heart and skeletal muscle lesions in the UM-X7.1 line. Muscle Nerve 5: 20–25, 1982

  19. 19.

    Proschek L, Jasmin G: Hereditary polymyopathy and cardiomyopathy in the Syrian hamster. II. Development of heart necrotic changes in relation to defective mitochondrial function. Muscle Nerve 5: 26–32, 1982

  20. 20.

    Dhalla NS, Anand-Srivastava MB, Khandelwal RL: Solubilization of a calcium dependent adenosine triphosphatase from rat heart sarcolemma. J Mol Cell Cardiol 13: 413–423, 1981

  21. 21.

    Jones LR, Maddok SW, Besch HR Jr: Unmasking effect of alamethicin on the Na-KATPase, β-adrenergic receptor-coupled adenylate cyclase and cAMP dependent protein kinase activities of cardiac sarcolemmal vesicles. J Biol Chem 255: 9971–9980, 1980

  22. 22.

    Seppet EK, Dhalla NS: Characteristics of calcium stimulated ATPase in rat heart sarcolemma in the presence of DTT and alamethicin. Mol Cell Biochem 91: 137–147, 1989

  23. 23.

    Tauskey H, Shorr: A microcaloric method for the esimation of inorganic phosphorous. J Biol Chem 202: 678–685, 1953

  24. 24.

    Sole MJ, Lo CM, Laird CW, Sonnenblick EH, Wrutman RJ: Norepinephrine turnover in the heart and spleen of the cardiomyopathic Sycian hamster. Circ Res 37: 855–862, 1975

  25. 25.

    Sethi R, Dhalla K, Shah KR, Dhalla NS: Characterization of adenylyl cyclase activity in heart sarcolemma in the absence or presence of alamethicin. Mol Cell Biochem 119: 185–193, 1993

  26. 26.

    Salmon Y, Londos C, Rodbell M: A highly sensitive adenylate cyclase assay. Anal Biochem 58: 541–548, 1974

  27. 27.

    Leammli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond) 227: 680–685, 1970

  28. 28.

    Mumby SM, Kahn RA, Manning DR, Gilman AG: Antisera of designed specifity for subunits of guanine nucleotide binding regulatory protein. Proc Natl Acad Sci USA 83: 265–269, 1986

  29. 29.

    Fowler MB, Laser JA, Hopkins GL, Minobe W, Bristow MR: Assessment of the beta adrenergic receptor pathway in the intact failing human heart: Progressive receptor downregulation and subsensitivity to agonist response. Circulation 74: 1280–1302, 1986

  30. 30.

    Feldman AM, Cates AE, Veazy WB, Hershberger RE, Bristow MT, Baughman KL, Baumgartner WA, Van Dop C: Increase of the 40,000 mol wt. pertussis toxin substrate (G-protein) in the failing human heart. J Clin Invest 82:189–197, 1988

  31. 31.

    Karliner JS, Alabaster C, Stephens H, Barnes P, Dollery C: Enhanced noradrenaline response in cardiomyopathic hamsters: possible relation to changes in adrenoceptors studied by radioligand binding. Cardiovasc Res 15: 296–304, 1981

Download references

Author information

Correspondence to Naranjan S. Dhalla.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Sethi, R., Bector, N., Takeda, N. et al. Alterations in G-proteins in congestive heart failure in cardiomyopathic (UM-X7.1) hamsters. Mol Cell Biochem 140, 163–170 (1994). https://doi.org/10.1007/BF00926754

Download citation

Key words

  • cardiomyopathic heart
  • norepinephrine turnover
  • beta-adrenergic receptors
  • adenylyl cyclase
  • G-proteins